Bullish Stocks Trading Higher Than Their Pivot Point: $MANH $STLD $MYOK

The Market Signal was created as a platform to help investors, if you own (NASDAQ:MANH), (NASDAQ:STLD) or (NASDAQ:MYOK) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

(Click link above or copy, paste and hit enter in your browser for your report)

Manhattan Associates Teams Up With Metapack To Offer Supply Chain Solutions


(Click link above or copy, paste and hit enter in your browser for your report)

Manhattan Associates, Inc. (NASDAQ:MANH) is trading at a higher price than its pivot point 96.10, thus indicating a bullish day. The company has teamed up with-commerce delivery technology company Metapack to launch direct External parcel Integration which will offer retailers quick access to their solutions. The EPI connects the company's warehouse management system with the delivery management platform of Metapack thus offering retailers seamless access to their eCommerce and omnichannel commerce tech solutions.

The enhancement will boost performance and reduce integration costs and time for retailers using the Manhattan Associates WMS capabilities and the delivery system of Metapack across warehouse locations globally.

Steel Dynamics To Hire Up To 600 Employees At The Sinton Steel Mill


(Click link above or copy, paste and hit enter in your browser for your report)

Steel Dynamics, Inc. (NASDAQ:STLD) is also indicating a bullish day and currently trades at a higher price than its pivot point 29.47. The company's new $1.9 billion steel mill in Sinton will hold open job applications for job seekers for around 600 positions through the end of this year. Currently, there are 75 employees at the site where construction in going with completion expected later in 2021. The mill could produce around 3 million tons of flat-rolled steel per year once it hits full production mode.

The company has declared a quarterly dividend of $0.25 per share on its common stock. The dividend will be payable on October 16, 2020, to shareholders who shall be on record on September 30, 2020.

Myokardia Announce Phase 3 EXPLORER-HCM Mavacamten Study Results


(Click link above or copy, paste and hit enter in your browser for your report)

Another stock indicating bullish sentiment is Myokardia Inc. (NASDAQ:MYOK) which is trading at a higher price than its pivot point 102.96. The company has released its Phase 3 EXPLORER-HCM clinical study results of Mavacamten in treating obstructive hypertrophic cardiomyopathy. The results were presented during the 2020 ESC Congress with publication in The Lancet. The company had previously released top-line results of the EXPLORER-HCM study that showed that patients under mavacamten treatment had significant improvement in functional status and symptoms.

Recently the company entered a strategic partnership for the commercialization of mavacamten with LianBio in Greater China and Asia. LianBio which launched recently aims to help in accelerating the availability of innovative medicine that addresses the unmet medical need in China.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.


comtex tracking


Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.